| Literature DB >> 25029436 |
Jörg Zehetner1, Steven R DeMeester, Evan T Alicuben, Daniel S Oh, John C Lipham, Jeffrey A Hagen, Tom R DeMeester.
Abstract
OBJECTIVE: The aim of the study was to evaluate laser-assisted fluorescent-dye angiography (LAA) to assess perfusion in the gastric graft and to correlate perfusion with subsequent anastomotic leak.Entities:
Mesh:
Year: 2015 PMID: 25029436 PMCID: PMC4463028 DOI: 10.1097/SLA.0000000000000811
Source DB: PubMed Journal: Ann Surg ISSN: 0003-4932 Impact factor: 12.969
FIGURE 1.Rapid and bright perfusion of the entire gastric graft by LAA.
FIGURE 2.A transition point is seen between rapid and bright versus slower, less robust perfusion (arrow). A suture is placed at the site of this transition point and if possible the anastomosis was placed proximal to this suture in an area of good perfusion by LAA.
Minor and Major Complications (n = 150)
| 52 (34.7%) | |
|---|---|
| Minor complications | |
| Wound infection | 10 (6.7%) |
| Wound hematoma, dehiscence | 2 (1.3%) |
| Urinary tract infection | 2 (1.3%) |
| Atrial fibrillation | 24 (16%) |
| Pulmonary complications | 13 (8.6%) |
| Deep venous thrombosis | 1 (0.7%) |
| Major complications | 33 (22%) |
| Perforation with NG tube | 1 (0.7%) |
| Leakage (minor/major) | 24 (16/8) |
| Chylothorax | 7 (4.6%) |
| Pulmonary Embolism | 1 (0.7%) |
| Mortality | 1 (0.7%) |
FIGURE 3.The frequency of major and minor leaks in patients where the anastomosis was placed in an area of good perfusion by LAA [either entire graft with good perfusion (n = 66) or anastomosis placed proximal to suture at site of transition (n = 29)] versus those patients that had an anastomosis placed at or distal to the site of the suture at the transition point (n = 49) (2% vs 45%, P < 0.0001).
Univariate Analysis of Factors Potentially Associated With Leak (n = 144)
| No Leak (n = 120) | Leak (n = 24) | ||
|---|---|---|---|
| Anastomosis at or distal to suture | 27 | 22 | <0.0001 |
| Cancer diagnosis | 104 | 23 | 0.31 |
| Diabetes | 23 | 5 | 0.78 |
| Hypertension | 57 | 18 | 0.0149 |
| Coronary artery disease | 25 | 3 | 0.41 |
| Active or recent smoking | 51 | 14 | 0.18 |
| Neoadjuvant therapy | 52 | 15 | 0.12 |
FIGURE 4.Perfusion by LAA shown in (A) qualitative mode versus (B) with quantitative (SPY-Q) overlay.